Es gab 50 kürzliche Insider-Transaktionen für BiomX Inc. (PHGE), darunter 32 Käufe und 15 Verkäufe. Die gesamten Insider-Käufe beliefen sich auf $8.99M und die gesamten Insider-Verkäufe auf $8.54M.
Bedeutende Insider mit kürzlicher Aktivität umfassen Yeganeh Reuven, Bidas Liat Cohavi, Flynn James E. Insider-Transaktionen können Einblicke geben, wie die Unternehmensführung die Bewertung und Zukunftsaussichten der Aktie einschätzt.
Insider-Transaktionen — PHGE
| Datum |
Name |
Funktion |
Transaktionsart |
Aktien |
Ø Preis |
Wert |
Gehaltene Aktien |
| 2026-03-17 |
Yeganeh Reuven |
10 Percent Owner |
Informierter Verkauf |
530,000 |
$5.00 |
$2.65M |
- |
| 2026-03-16 |
Yeganeh Reuven |
10 Percent Owner |
Informierter Verkauf |
1,700,000 |
$1.00 |
$1.7M |
- |
| 2026-03-13 |
Yeganeh Reuven |
10 Percent Owner |
Informierter Verkauf |
370,000 |
$5.00 |
$1.85M |
- |
| 2026-03-12 |
Yeganeh Reuven |
10 Percent Owner |
Umwandlung (Verkauf) |
600 |
$2.00 |
$1.2K |
2,700 |
| 2026-03-11 |
Yeganeh Reuven |
10 Percent Owner |
Umwandlung (Kauf) |
300,000 |
$2.00 |
$600K |
30,000 |
| 2026-02-13 |
Bidas Liat Cohavi |
Director |
Unbekannt |
- |
- |
- |
- |
| 2026-01-02 |
Yeganeh Reuven |
10 Percent Owner |
Unbekannt |
1,650,000 |
$2.00 |
$3.3M |
- |
| 2025-04-21 |
Flynn James E |
Other: *director By Deputization |
RSU-Zuteilung |
1,611,864 |
$0.93 |
$1.5M |
1,611,864 |
| 2025-04-14 |
Leff Jonathan S |
Director |
RSU-Rückgabe |
17,600 |
$0.54 |
$9.47K |
17,600 |
| 2025-04-14 |
Flynn James E |
Other: *director By Deputization |
RSU-Zuteilung |
17,600 |
$0.54 |
$9.47K |
17,600 |
| 2025-04-14 |
Williams Eddie |
Director |
RSU-Rückgabe |
17,600 |
$0.54 |
$9.47K |
17,600 |
| 2025-04-14 |
Goodman Jesse |
Director |
RSU-Rückgabe |
17,600 |
$0.54 |
$9.47K |
17,600 |
| 2025-04-14 |
Greig Russell |
Director |
RSU-Rückgabe |
35,200 |
$0.54 |
$18.94K |
35,200 |
| 2025-04-14 |
Blum Susan |
Director |
RSU-Rückgabe |
17,600 |
$0.54 |
$9.47K |
17,600 |
| 2025-04-14 |
Solomon Jonathan Eitan |
Chief Executive Officer |
RSU-Zuteilung |
126,748 |
- |
- |
126,748 |
| 2025-04-14 |
Bassan Merav |
Chief Development Officer |
RSU-Zuteilung |
79,597 |
- |
- |
79,597 |
| 2025-04-14 |
Wolfson Marina |
Chief Financial Officer |
RSU-Zuteilung |
68,545 |
- |
- |
68,545 |
| 2025-04-14 |
Moses Alan Charles |
Director |
RSU-Rückgabe |
17,600 |
$0.54 |
$9.47K |
17,600 |
| 2025-04-14 |
Leff Jonathan S |
Director |
RSU-Zuteilung |
17,600 |
$0.54 |
$9.47K |
17,600 |
| 2025-04-14 |
Williams Eddie |
Director |
RSU-Zuteilung |
17,600 |
$0.54 |
$9.47K |
17,600 |
| 2025-04-14 |
Goodman Jesse |
Director |
RSU-Zuteilung |
17,600 |
$0.54 |
$9.47K |
17,600 |
| 2025-04-14 |
Greig Russell |
Director |
RSU-Zuteilung |
35,200 |
$0.54 |
$18.94K |
35,200 |
| 2025-04-14 |
Blum Susan |
Director |
RSU-Zuteilung |
17,600 |
$0.54 |
$9.47K |
17,600 |
| 2025-04-14 |
Solomon Jonathan Eitan |
Chief Executive Officer |
RSU-Zuteilung |
380,500 |
$0.54 |
$204.71K |
380,500 |
| 2025-04-14 |
Bassan Merav |
Chief Development Officer |
RSU-Zuteilung |
95,000 |
$0.54 |
$51.11K |
95,000 |
| 2025-04-14 |
Wolfson Marina |
Chief Financial Officer |
RSU-Zuteilung |
95,000 |
$0.54 |
$51.11K |
95,000 |
| 2025-04-14 |
Moses Alan Charles |
Director |
RSU-Zuteilung |
17,600 |
$0.54 |
$9.47K |
17,600 |
| 2025-04-14 |
Merril Gregory Louis |
Director |
RSU-Zuteilung |
17,600 |
$0.54 |
$9.47K |
17,600 |
| 2025-02-27 |
Flynn James E |
Other: *director By Deputization |
Optionsausübung (Verkauf) |
1,611,863 |
- |
- |
405,637 |
| 2025-02-26 |
Cystic Fibrosis Foundation |
Officer |
Unbekannt |
- |
- |
- |
- |
| 2024-09-16 |
Oron Assaf |
Chief Business Officer |
RSU-Zuteilung |
25,804 |
- |
- |
25,804 |
| 2024-09-16 |
Solomon Jonathan Eitan |
Chief Executive Officer |
RSU-Zuteilung |
50,556 |
- |
- |
53,056 |
| 2024-09-16 |
Bassan Merav |
Chief Development Officer |
RSU-Zuteilung |
31,749 |
- |
- |
31,749 |
| 2024-07-15 |
Cystic Fibrosis Foundation |
10 Percent Owner |
Umwandlung (Verkauf) |
8,547 |
- |
- |
13,088 |
| 2024-07-15 |
Flynn James E |
Other: *director By Deputization |
Optionsausübung (Verkauf) |
5,883 |
- |
- |
47,957 |
| 2024-07-11 |
Leff Jonathan S |
Director |
RSU-Zuteilung |
264,000 |
$0.36 |
$95.83K |
264,000 |
| 2024-07-11 |
Flynn James E |
Other: *director By Deputization |
RSU-Zuteilung |
264,000 |
$0.36 |
$95.83K |
264,000 |
| 2024-07-11 |
Williams Eddie |
Director |
RSU-Zuteilung |
176,000 |
$0.36 |
$63.89K |
176,000 |
| 2024-07-11 |
Goodman Jesse |
Director |
RSU-Zuteilung |
264,000 |
$0.36 |
$95.83K |
264,000 |
| 2024-07-11 |
Greig Russell |
Director |
RSU-Zuteilung |
352,000 |
$0.36 |
$127.78K |
352,000 |
| 2024-07-11 |
Blum Susan |
Director |
RSU-Zuteilung |
264,000 |
$0.36 |
$95.83K |
264,000 |
| 2024-07-11 |
Oron Assaf |
Chief Business Officer |
RSU-Zuteilung |
237,500 |
$0.36 |
$86.21K |
237,500 |
| 2024-07-11 |
Solomon Jonathan Eitan |
Chief Executive Officer |
RSU-Zuteilung |
3,805,000 |
$0.36 |
$1.38M |
3,805,000 |
| 2024-07-11 |
Bassan Merav |
Chief Development Officer |
RSU-Zuteilung |
950,000 |
$0.36 |
$344.85K |
950,000 |
| 2024-07-11 |
Wolfson Marina |
Chief Financial Officer |
RSU-Zuteilung |
950,000 |
$0.36 |
$344.85K |
950,000 |
| 2024-07-11 |
Moses Alan Charles |
Director |
RSU-Zuteilung |
176,000 |
$0.36 |
$63.89K |
176,000 |
| 2024-07-11 |
Merril Gregory Louis |
Director |
RSU-Zuteilung |
264,000 |
$0.36 |
$95.83K |
264,000 |
| 2024-07-09 |
Flynn James E |
10 Percent Owner, Other: *director By Deputization |
RSU-Zuteilung |
722,175 |
$5.00 |
$3.61M |
722,175 |
| 2024-05-15 |
Cystic Fibrosis Foundation |
10 Percent Owner |
Optionsausübung (ITM) |
4,778,265 |
$0.00 |
$4.78K |
- |
| 2024-05-15 |
Orbimed Israel Biofund Gp Limited Partnership |
10 Percent Owner |
Optionsausübung (ITM) |
9,280,408 |
$0.24 |
$2.26M |
- |
■ Informativ — Transaktion am offenen Markt (bedeutendste)
■ Nicht-informativ (Kauf) — Vergütung, Optionsausübung, Wandlung
■ Nicht-informativ (Verkauf) — Quellensteuer, Verkauf bei Vesting
■ Neutral — Schenkung, Treuhand, Verfall
